Clinical Trials Directory

Trials / Completed

CompletedNCT00368784

T Cell Repertoire Analysis of Immune Mediated Skin Diseases

Status
Completed
Phase
Study type
Observational
Enrollment
426 (actual)
Sponsor
University of California, Davis · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

This study is designed to identify the cells of the immune system that cause skin disease such as psoriasis and mycosis fungoides. Blood samples from many patients will be compared in hopes of finding common cells and molecules responsible for skin diseases. Results of this study will increase our knowledge about immune mediated skin disease.

Detailed description

The aim of the study is to characterized the T cell repertoire of individuals with immune mediated skin disease (e.g. psoriasis and mycosis fungoides). Peripheral blood with be collected from volunteers with psoriasis, mycosis fungoides and age matched controls. Fifteen tablespoons of blood will be collected prior to the initiation of treatment and again after the patient shows a clinical response to treatment. The time between blood draws will be no less than 3 months. There will be no more than two blood draws per patient. Blood samples will be used to determine the patient's HLA haplotype via PCR and DNA sequencing. After the patient's haplotype has been established the activated T cell repertoire will be analyzed for clonal expansions. Clonal expansions in the T cell repertoire will be determined by immunoscope analysis, which is a PCR based technique.

Conditions

Timeline

Start date
2007-01-01
Primary completion
2020-11-01
Completion
2020-11-01
First posted
2006-08-25
Last updated
2025-05-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00368784. Inclusion in this directory is not an endorsement.